Anabolic Steroid Abuse and Dependence in Clinical Practice

References

• . Quaglio G, Fornasiero A, Mezzelani P, Moreschini S, Lugoboni F, Lechi A. Anabolic steroids: dependence and complications of chronic use. Intern Emerg Med. 2009;4(4):289–296.
   PubMed Web of Science ®Google Scholar
• . Thiblin I, Petersson A. Pharmacoepidemiology of anabolic androgenic steroids: a review. Fundam Clin Pharmacol. 2005;19(1):27–44.
   PubMed Web of Science ®Google Scholar
• . Sjöqvist F, Garle M, Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet. 2008;371(9627):1872–1882.
   PubMed Web of Science ®Google Scholar
• . Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol. 2008;154(3):502–521.
   PubMed Web of Science ®Google Scholar
• . Kanayama G, Hudson JI, Pope HG. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend. 2008;98(1–2):1–12.
   PubMed Web of Science ®Google Scholar
• . Hoffman JR, Faigenbaum AD, Ratamess NA, Ross R, Kang J, Tenenbaum G. Nutritional supplementation and anabolic steroid use in adolescents. Med Sci Sports Exerc. 2008;40(1):15–24.
   PubMed Web of Science ®Google Scholar
• . Bonetti A, Tirelli F, Catapano A, . Side effects of anabolic androgenic steroids abuse. Int J Sports Med. 2008;29(8):679–687.
   PubMed Web of Science ®Google Scholar
• . Evans NA. Current concepts in anabolic-androgenic steroids. Am J Sports Med. 2004;32(2):534–542.
   PubMed Web of Science ®Google Scholar
• . Talih F, Fattal O, Malone DJ. Anabolic steroid abuse: psychiatric and physical costs. Cleve Clin J Med. 2007;74(5):341–344.
   PubMed Web of Science ®Google Scholar
• . Yesalis CE, Kennedy NJ, Kopstein AN, Bahrke MS. Anabolic-androgenic steroid use in the United States. JAMA. 1993;270(10):1217–1221.
   PubMed Web of Science ®Google Scholar
• . Pope HG Jr, Brower KJ. Treatment of anabolic-androgenic steroid-related disorders. In: Galanter M, Kleber HD, eds. Textbook of Substance Abuse Treatment. 4th ed. Washington, DC: American Psychiatric Publishing; 2008:237–245.
   Google Scholar
• . Leone JE, Sedory EJ, Gray KA. Recognition and treatment of muscle dysmorphia and related body image disorders. J Athl Train. 2005;40(4):352–359.
   PubMed Web of Science ®Google Scholar
• . Tan RS, Vasudevan D. Use of clomiphene citrate to reverse premature andropause secondary to steroid abuse. Fertil Steril. 2003;79(1):203–205.
   PubMed Web of Science ®Google Scholar
• . Menon DK. Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin. Fertil Steril. 2003;79( suppl 3):1659–1661.
   PubMed Web of Science ®Google Scholar
• . Frankle M, Leffers D. Athletes on anabolic-androgenic steroids: new approach diminishes health problems. Phys Sportsmed. 1992;20(6):75–87.
   PubMed Web of Science ®Google Scholar
• . Corcoran JP, Longo EL. Psychological treatment of anabolic-androgenic steroid-dependent individuals. J Subst Abuse Treat. 1992;9(3):229–235.
   PubMed Web of Science ®Google Scholar
• . Williamson K, Davies M, McBride A. A well-steroid user clinic. Druglink. 1992;15.
   Google Scholar
• . Brower KJ. Anabolic steroid abuse and dependence. Curr Psychiatry Rep. 2002;4(5):377–387.
   PubMedGoogle Scholar
• . Giannini AJ, Miller N, Kocjan DK. Treating steroid abuse: a psychiatric perspective. Clin Pediatr (Phila). 1991;30(9):538–542.
   PubMed Web of Science ®Google Scholar
• . McAllister MS, Collins GB. Anabolic-androgenic steroid abuse by physicians. J Addict Dis. 2006;25(3):105–110.
   PubMed Web of Science ®Google Scholar
• . Clancy GP, Yates WR. Anabolic steroid use among substance abusers in treatment. J Clin Psychiatry. 1992;53(3):97–100.
   PubMed Web of Science ®Google Scholar
• . Kanayama G, Cohane GH, Weiss RD, Pope HG. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem? J Clin Psychiatry. 2003;64(2):156–160.
   PubMed Web of Science ®Google Scholar
• . Pope HG, Kanayama G, Ionescu-Pioggia M, Hudson JI. Anabolic steroid users' attitudes towards physicians. Addiction. 2004;99(9):1189–1194.
   PubMed Web of Science ®Google Scholar
• . American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
   Google Scholar
• . Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr. Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence. Am J Psychiatry. 2009;166(6):642–645.
   PubMed Web of Science ®Google Scholar
• . Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr. Anabolicandrogenic steroid dependence: an emerging disorder. Addiction. In press.
   Google Scholar
• . Bhasin S, Cunningham GR, Hayes FJ, . Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2006;91(6):1995–2010.
   PubMed Web of Science ®Google Scholar
• . Millar AP. Licit steroid use—hope for the future. Br J Sports Med. 1994;28(2):79–83.
   PubMed Web of Science ®Google Scholar
• . Skarberg K, Nyberg F, Engstrom I. Multisubstance use as a feature of addiction to anabolic-androgenic steroids. Eur Addict Res. 2009;15(2):99–106.
   PubMed Web of Science ®Google Scholar
• . Calfee R, Fadale P. Popular ergogenic drugs and supplements in young athletes. Pediatrics. 2006;117(3):e577–e589.
   PubMed Web of Science ®Google Scholar
• . Brown GA, Vukovich M, King DS. Testosterone prohormone supplements. Med Sci Sports Exerc. 2006;38(8):1451–1461.
   PubMed Web of Science ®Google Scholar
• . Saugy M, Robinson N, Saudan C, Baume N, Avois L, Mangin P. Human growth hormone doping in sport. Br J Sports Med. 2006;40( suppl 1):i35–i39.
   PubMed Web of Science ®Google Scholar
• . Striegel H, Simon P, Frisch S, . Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system. Drug Alcohol Depend. 2006;81(1):11–19.
   PubMed Web of Science ®Google Scholar
• . Steensland P, Hallberg M, Kindlundh A, Fahlke C, Nyberg F. Amphetamine-induced aggression is enhanced in rats pre-treated with the anabolic androgenic steroid nandrolone decanoate. Steroids. 2005;70(3):199–204.
   PubMed Web of Science ®Google Scholar
• . Tan RS, Scally MC. Anabolic steroid-induced hypogonadism—towards a unified hypothesis of anabolic steroid action. Med Hypotheses. 2009;72(6):723–728.
   PubMed Web of Science ®Google Scholar
• . Melchert RB, Welder AA. Cardiovascular effects of androgenic-anabolic steroids. Med Sci Sports Exerc. 1995;27(9):1252–1262.
   PubMed Web of Science ®Google Scholar
• . Sullivan ML, Martinez CM, Gennis P, Gallagher EJ. The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis. 1998;41(1):1–15.
   PubMed Web of Science ®Google Scholar
• . Payne J, Kotwinski PJ, Montgomery HE. Cardiac effects of anabolic steroids. Heart. 2004;90(5):473–475.
   PubMed Web of Science ®Google Scholar
• . Modlinski R, Fields KB. The effect of anabolic steroids on the gastrointestinal system, kidneys, and adrenal glands. Curr Sports Med Rep. 2006;5(2):104–109.
   PubMedGoogle Scholar
• . Socas L, Zumbado M, Perez-Luzardo O, . Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med. 2005;39(5):e27.
   Web of Science ®Google Scholar
• . Gorayski P, Thompson CH, Subhash HS, Thomas AC. Hepatocellular carcinoma associated with recreational anabolic steroid use. Br J Sports Med. 2008;42(1):74–75.
   PubMed Web of Science ®Google Scholar
• . Bain J, Brock G, Kuzmarov I. Canadian Society for the Study of the Aging Male: response to health Canada's position paper on testosterone treatment. J Sex Med. 2007;4(3):558–566.
   PubMed Web of Science ®Google Scholar
• . Petersson A, Garle M, Granath F, Thiblin I. Convulsions in users of anabolic androgenic steroids: possible explanations. J Clin Psychopharmacol. 2007;27(6):723–725.
   PubMed Web of Science ®Google Scholar
• . Rogol AD, Martha PM Jr, Blizzard RM. Anabolic-androgenic steroids profoundly affect growth at puberty in boys. NIDA Res Monogr. 1990;102:187–195.
   PubMedGoogle Scholar
• . Trenton AJ, Currier GW. Behavioural manifestations of anabolic steroid use. CNS Drugs. 2005;19(7):571–595.
   PubMed Web of Science ®Google Scholar
• . Hall RC, Chapman MJ. Psychiatric complications of anabolic steroid abuse. Psychosomatics. 2005;46(4):285–290.
   PubMed Web of Science ®Google Scholar
• . Genazzani AR, Pluchino N, Freschi L, Ninni F, Luisi M. Androgens and the brain. Maturitas. 2007;57(1):27–30.
   PubMed Web of Science ®Google Scholar
• . Clark AS, Henderson LP. Behavioral and physiological responses to anabolic-androgenic steroids. Neurosci Biobehav Rev. 2003;27(5):413–436.
   PubMed Web of Science ®Google Scholar
• . Kanayama G, Amiaz R, Seidman S, Pope HG. Testosterone supplementation for depressed men: current research and suggested treatment guidelines. Exp Clin Psychopharmacol. 2007;15(6):529–538.
   PubMed Web of Science ®Google Scholar
• . Beauchet O. Testosterone and cognitive function: current clinical evidence of a relationship. Eur J Endocrinol. 2006;155(6):773–781.
   PubMed Web of Science ®Google Scholar
• . Janowsky JS. Thinking with your gonads: testosterone and cognition. Trends Cogn Sci. 2006;10(2):77–82.
   PubMed Web of Science ®Google Scholar
• . Hajszan T, MacLusky NJ, Johansen JA, Jordan CL, Leranth C. Effects of androgens and estradiol on spine synapse formation in the prefrontal cortex of normal and testicular feminization mutant male rats. Endocrinology. 2007;148(5):1963–1967.
   PubMed Web of Science ®Google Scholar
• . Spritzer MD, Galea LA. Testosterone and dihydrotestosterone, but not estradiol, enhance survival of new hippocampal neurons in adult male rats. Dev Neurobiol. 2007;67(10):1321–1333.
   PubMed Web of Science ®Google Scholar
• . Pagonis TA, Angelopoulos NV, Koukoulis GN, Hadjichristodoulou CS. Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse. Eur Psychiatry. 2006;21(8):551–562.
   PubMed Web of Science ®Google Scholar
• . Malone DA Jr, Dimeff RJ, Lombardo JA, Sample RH. Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users. Clin J Sport Med. 1995;5(1):25–31.
   PubMed Web of Science ®Google Scholar
• . Thiblin I, Runeson B, Rajs J. Anabolic androgenic steroids and suicide. Ann Clin Psychiatry. 1999;11(4):223–231.
   PubMedGoogle Scholar
• . Klotz F, Petersson A, Isacson D, Thiblin I. Violent crime and substance abuse: a medico-legal comparison between deceased users of anabolic androgenic steroids and abusers of illicit drugs. Forensic Sci Int. 2007;173(1):57–63.
   PubMed Web of Science ®Google Scholar
• . Petersson A, Garle M, Holmgren P, Druid H, Krantz P, Thiblin I. Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids. Drug Alcohol Depend. 2006;81(3):241–249.
   PubMed Web of Science ®Google Scholar
• . Elofson G, Elofson S. Steroids claimed our son's life. Phys Sportsmed. 1990;18:15–16.
   PubMed Web of Science ®Google Scholar
• . Vjorkqvist KT, Bjorklund AC, Bjorkqvist SE. Testosterone intake and aggressiveness: real effect of anticipation. Aggress Behav. 1994;20:17–26.
   Web of Science ®Google Scholar
• . Bahrke MS, Yesalis CE 3rd, Wright JE. Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids. An update. Sports Med. 1996;22(6):367–390.
   PubMed Web of Science ®Google Scholar
• . Thiblin I, Mobini-Far H, Frisk M. Sudden unexpected death in a female fitness athlete, with a possible connection to the use of anabolic androgenic steroids (AAS) and ephedrine. Forensic Sci Int. 2009;184(1–3):e7–e11.
   Web of Science ®Google Scholar
• . Thiblin I, Lindquist O, Rajs J. Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci. 2000;45(1):16–23.
   PubMed Web of Science ®Google Scholar
• . Perry PJ, Lund BC, Deninger MJ, Kutscher EC, Schneider J. Anabolic steroid use in weightlifters and bodybuilders: an internet survey of drug utilization. Clin J Sport Med. 2005;15(5):326–330.
   PubMed Web of Science ®Google Scholar
• . Kanayama G, Hudson JI, Pope HG Jr. Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers. Drug Alcohol Depend. 2009;102(1–3):130–137.
   PubMed Web of Science ®Google Scholar
• . Fudala PJ, Weinrieb RM, Calarco JS, Kampman KM, Boardman C. An evaluation of anabolic-androgenic steroid abusers over a period of 1 year: seven case studies. Ann Clin Psychiatry. 2003;15(2):121–130.
   PubMedGoogle Scholar
• . Wood RI. Anabolic-androgenic steroid dependence? Insights from animals and humans. Front Neuroendocrinol. 2008;29(4):490–506.
   PubMed Web of Science ®Google Scholar
• . Peters KD, Wood RI. Androgen dependence in hamsters: overdose, tolerance, and potential opioidergic mechanisms. Neuroscience. 2005;130(4):971–981.
   PubMed Web of Science ®Google Scholar
• . Wood RI. Anabolic steroids: a fatal attraction? J Neuroendocrinol. 2006;18(3):227–228.
   PubMed Web of Science ®Google Scholar
• . Birgner C, Kindlundh-Hogberg AM, Nyberg F, Bergstrom L. Altered extracellular levels of DOPAC and HVA in the rat nucleus accumbens shell in response to sub-chronic nandrolone administration and a subsequent amphetamine challenge. Neurosci Lett. 2007;412(2):168–172.
   PubMed Web of Science ®Google Scholar
• . Hurst R, Hale B, Smith D, Collins D. Exercise dependence, social physique anxiety, and social support in experienced and inexperienced bodybuilders and weightlifters. Br J Sports Med. 2000;34(6):431–435.
   PubMed Web of Science ®Google Scholar
• . Armsey TD, Hosey RG. Medical aspects of sports: epidemiology of injuries, preparticipation physical examination, and drugs in sports. Clin Sports Med. 2004;23(2):255–279.
   PubMed Web of Science ®Google Scholar
• . Pope HG, Gruber AJ, Choi P, Olivardia R, Phillips KA. Muscle dysmorphia. An underrecognized form of body dysmorphic disorder. Psychosomatics. 1997;38(6):548–557.
   PubMed Web of Science ®Google Scholar
• . Grieve FG. A conceptual model of factors contributing to the development of muscle dysmorphia. Eat Disord. 2007;15(1):63–80.
   PubMedGoogle Scholar
• . Baum A. Eating disorders in the male athlete. Sports Med. 2006;36(1):1–6.
   PubMed Web of Science ®Google Scholar
• . Chung B. Muscle dysmorphia: a critical review of the proposed criteria. Perspect Biol Med. 2001;44(4):565–574.
   PubMed Web of Science ®Google Scholar
• . Rohman L. The relationship between anabolic androgenic steroids and muscle dysmorphia: a review. Eat Disord. 2009;17(3):187–199.
   PubMedGoogle Scholar
• . Ray R, Wiese-Bjornstal DM, eds. Counseling in Sports Medicine. Champaign, IL: Human Kinetics; 1999.
   Google Scholar
• . Spector ND, Chanoine P. Hypertension, sports supplements and motivational interviewing. Curr Opin Pediatr. 2007;19(6):726–732.
   PubMed Web of Science ®Google Scholar
• . Hettema J, Steele J, Miller WR. Motivational interviewing. Annu Rev Clin Psychol. 2005;1:91–111.
   PubMed Web of Science ®Google Scholar
• . Collins GB, Pippenger CE, Janesz JW. Links in the chain: an approach to the treatment of drug abuse on a professional football team. Cleveland Clinical Quarterly. 1984;51:485–492.
   PubMedGoogle Scholar
• . Malone DA Jr, Dimeff RJ. The use of fluoxetine in depression associated with anabolic steroid withdrawal: a case series. J Clin Psychiatry. 1992;53:130–132.
   PubMed Web of Science ®Google Scholar
• . Malone DA Jr, Dimeff RJ. The use of fluoxetine in depression associated with anabolic steroid withdrawal: a case series. J Clin Psychiatry. 1992;53(4):130–132.
   PubMed Web of Science ®Google Scholar
• . Brower KJ. Withdrawal from anabolic steroids. Curr Ther Endocrinol Metab. 1997;6:338–343.
   PubMedGoogle Scholar
• . Jarow JP, Lipshultz LI. Anabolic steroid-induced hypogonadotropic hypogonadism. Am J Sports Med. 1990;18(4):429–431.
   PubMed Web of Science ®Google Scholar
• . American Psychiatric Association. Practice guideline for the treatment of patients with substance use disorders, second edition. Am J Psychiatry. 2007;164( 4 Suppl):5–123.
   Web of Science ®Google Scholar
• . Yesalis CE. Winning and performance-enhancing drugs—our dual addiction. Phys Sportsmed. 1990;18:161–167.
   PubMed Web of Science ®Google Scholar